Compare CWBC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWBC | ANGO |
|---|---|---|
| Founded | 1989 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.8M | 400.8M |
| IPO Year | 1996 | 2004 |
| Metric | CWBC | ANGO |
|---|---|---|
| Price | $23.76 | $13.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $21.67 | $19.33 |
| AVG Volume (30 Days) | 141.3K | ★ 465.8K |
| Earning Date | 01-24-2026 | 01-07-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 309.32 | N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | $138,038,000.00 | ★ $300,718,000.00 |
| Revenue This Year | $32.04 | $8.18 |
| Revenue Next Year | $7.24 | $5.15 |
| P/E Ratio | $13.34 | ★ N/A |
| Revenue Growth | ★ 45.08 | 2.73 |
| 52 Week Low | $15.57 | $8.27 |
| 52 Week High | $23.99 | $13.99 |
| Indicator | CWBC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 74.77 | 58.82 |
| Support Level | $22.48 | $13.12 |
| Resistance Level | $23.99 | $13.53 |
| Average True Range (ATR) | 0.43 | 0.43 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 90.43 | 61.80 |
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.